Cross-category comparison
Lifestyle Alone vs Mounjaro
Different categories, normalised only where comparison is meaningful.
Structured lifestyle programme
Moderate on average, highly variable
VS
Mounjaro
Up to ~20%+ mean loss in obesity trials; direct head-to-head 20.2% at 72 weeks vs 13.7% semaglutide 1.7/2.4 mg in SURMOUNT-5
Shared dimensions
| Dimension | Structured lifestyle programme | Mounjaro |
|---|---|---|
| Relative weight-loss potential / intensity | 5/10 | 10/10 |
| Typical speed / access to effect | 4/10 | 8/10 |
| Lower procedural / medical burden | 10/10 | 5/10 |
| Ease of stopping, reversing or changing route | 10/10 | 9/10 |
| Lower cost / easier access | 9/10 | 4/10 |
| Long-term maintenance simplicity | 10/10 | 6/10 |
| Evidence maturity / depth | 9/10 | 10/10 |
| Day-to-day or pathway convenience | 10/10 | 8/10 |
Category-specific detail
| Issue | Structured lifestyle programme | Mounjaro |
|---|---|---|
| Appetite support | Does not directly pharmacologically suppress appetite | Not applicable |
| Approach | Nutrition + physical activity + behavioural support | Not applicable |
| Cost | Can be low | Not applicable |
| Evidence anchor | Not applicable | Up to ~20%+ mean loss in obesity trials; direct head-to-head 20.2% at 72 weeks vs 13.7% semaglutide 1.7/2.4 mg in SURMOUNT-5 |
| How it works | Not applicable | Dual GIP/GLP-1 receptor agonist |
| How taken | Not applicable | Weekly injection — Once weekly |
| Main trade-offs | Not applicable | Injection; GI side effects can be limiting; Access and NHS rollout are not the same as NICE eligibility; Ongoing treatment cost/maintenance matters if private |
| Maintenance | Skills can be maintained indefinitely; relapse plan still needed | Long-term treatment may be needed; stopping can be followed by regain |
| Medical intensity | Low | Not applicable |
| Muscle support | Strength training + adequate protein can actively support lean mass | Not applicable |
| NHS context | Not applicable | NICE-recommended; NHS access is phased / pathway-dependent |
| Speed | Gradual | Not applicable |
| UK licence | Not applicable | UK weight management licence |
| Weight-loss potential | Moderate on average, highly variable | Not applicable |
Do not add the scores together.
The bars are there to expose trade-offs. They are not a validated overall suitability index.
Built for informed decisions. Our health content is evidence-led, regularly reviewed, and designed to explain options clearly without pretending a website can replace clinical assessment.
Continue exploring